Aura Biosciences, Inc. (AURA)

NASDAQ: AURA · IEX Real-Time Price · USD
17.02
-0.64 (-3.62%)
May 20, 2022 4:00 PM EDT - Market closed

Cash Flow Statement (Quarterly)

Millions USD. Fiscal year is Jan - Dec.
Quarter Ended2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
Net Income
-12.84-11.63-8.84--8.26-4.91-3.63
Depreciation & Amortization
0.260.230.22-0.190.230.23
Share-Based Compensation
1.591.30.55-0.190.180.19
Other Operating Activities
-4.22-1.98-0.6202.750.75-3.4
Operating Cash Flow
-15.2-12.09-8.69--5.14-3.76-6.61
Capital Expenditures
-0.6-0.82-0.57--0.07-0.13-0.1
Change in Investments
-24.900-000
Investing Cash Flow
-25.5-0.82-0.57--0.07-0.13-0.1
Share Issuance / Repurchase
0.0278.740.02-0.270.020.02
Other Financing Activities
01.4-1.14087.225.124.78
Financing Cash Flow
0.0280.14-1.12-87.495.134.8
Net Cash Flow
-40.6867.24-10.38-82.281.24-1.46
Free Cash Flow
-15.8-12.91-9.26--5.21-3.89-6.71
Free Cash Flow Per Share
-0.54-2.50-20.98--13.01-10.22-17.82
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).